Presenilin-1 deficiency leads to loss of Cajal-Retzius neurons and cortical dysplasia similar to human type 2 lissencephaly

Current Biology

Volumn 9, Issue 14, 1999, Pages 719-727

  Hartmann, Dieter ^a   De Strooper, Bart ^b   Saftig, Paul ^c  

^a Kiel and Lungen Clinic Grosshansdorf   (Germany)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c Molekulare Zellbiologie   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA;

EID: 0033565962     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-9822(99)80331-5     Document Type: Article

References (52)

1. Kovacs DM, Fausett HJ, Page KJ, Kim TW, Moir RD, Merriam DE, et al.: Alzheimer-associated presenilins 1 and 2: Neuronal expression in brain and localization to intracellular membranes in mammalian cells. Nature Med 1996, 2:224-229.
2. Walter J, Capell A, Grunberg J, Pesold B, Schindzielorz A, Prior R, et al.: The alzheimer's disease-associated presenilins are differentially phosphorylated proteins located predominantly within the endoplasmic reticulum. Mol Med 1996, 2:673-691.
3. De Strooper B, Beullens M, Contreras B, Levesque L, Craessaerts K, Cordell B, et al.: Phosphorylation, subcellular localisation, and membrane orientation of the Alzheimer's disease-associated presenilins. J Biol Chem 1997, 272:3590-3598.
4. Sherrington R, Rogaev El, Liang Y, Rogaeva E, Levesque G, Ikeda M, et al.: Cloning of a gene bearing missense mutations in early onset familial Alzheimer's disease. Nature 1995, 375:754-760.
5. Cribbs D, Chen L, Bende SM, LaFerla FM: Widespread neuronal expression of the presenilin-1 early-onset Alzheimer's disease gene in the murine brain. Am J Pathol 1996,148:1797-1806.
6. Lee MK, Slunt HH, Martin LJ, Thinakaran G, Kim S, Gandy SE, et al.: Expression of presenilin 1 and 2 (PS1 and PS2) in human and murine tissues. J Neurosci 1996, 16:7513-7525.
7. Suzuki T, Nishiyama K, Murayama S, Yamamoto A, SAto S, Kanazawa I, Sakaki Y: Regional and cellular presenilin 1 gene expression in human and rat tissues. Biochem Biophys Res Commun 1996, 219:708-713.
8. Hartmann H, Busciglio J, Baumann KH, Staufenbiel M, Yankner BA: Developmental regulation of presenilin-1 processing in the brain suggests a role in neuronal differentiation. J Biol Chem 1997, 272:14505-14508.
9. Scheuner D, Eckman C, Jensen M, Song X, Citron M, Suzuki N, et al.: Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nature Med 1996, 2:864-870.
10. Duff K, Eckman C, Zher C, Yu X, Prada CM, Perez-Tur J, et al.: Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1. Nature 1996, 383:710-713.
11. Borchelt DR, Thinakaran G, Eckman CB, Lee MK, Davenport F, RatovitskyT, et al: familial Alzheimer's disease-linked presenilin 1 variants elevate Ab1-42/1-40 ratio in vitro and in vivo. Neuron 1996, 17:1005-1013.
12. Citron M, Westaway D, Xia W, Carlson G, Diehl T, Levesque G, et al.: Mutant presenilins of alzheimer's disease increase production of 42 residue amyloid beta-protein in both transfected cells and transgenic mice. Nature Med 1997, 3:67-72.
13. De Strooper B, Saftig P, Craessaerts K, Vanderstichele H, Guhde G, Annaert W, et al.: Deficiency of presenilin 1 inhibits the normal cleavage of amyloid precursor protein. Nature 1998, 391:387-390.
14. Zheng H, Jiang M, Trumbauer ME, Sirinathsinghji DJ, Hopkins R, Smith DW, et al.: β-amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activity. Cell 1995, 81:525-531.
15. Shen J, Bronson RT, Chen DF, Xia W, Selkoe D, Tonegawa S: Skeletal and CNS defects in presenilin-1 deficient mice. Cell 1997, 89:629-639.
16. Wong PC, Zheng H, Chen H, Becher MW, Sirinathsinghji DJS, Trumbauer ME, et al.: Presenilin 1 is required for Notch I and DII 1 expression in the paraaxial mesoderm. Nature 1997, 387:288-292.
17. Levitan D, Greenwald L: Facilitation of lin-12-mediated signalling by sel-12, a Caenorhabditis elegans S182 Alzheimer's disease gene. Nature 1995, 377:351-354.
18. Struhl G, Adachi A: Nuclear access and action of Notch in vivo. Cell 1998, 93:649-660.
19. Schroeter EH, Kisslinger JA, Kopan R: Notch1 signaling requires ligand-induced proteolytic release of intracellular domain. Nature 1998, 393:382-386.
20. De Strooper B, Annaert W, Cupers P, Saftig P, Craessaerts K, Mumm JS, et al.: A presenilin-1-dependent, gamma secretase-like protease mediates release of Notch intracellular domain. Nature 1999, 398:518-522.
21. Struhl G, Greenwald I: Presenilin is required for activity and nuclear access of Notch in Drosophila. Nature 1999, 398:522-525.
22. Wolfe MS, Xia W, Ostaszewski BL, Diehl TS, Kimberly WT, Selkoe DJ: Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity. Nature 1999, 398:513-517.
23. Super H, Martinez A, Soriano E: Degeneration of Cajal-Retzius cells in the developing cerebral cortex of the mouse after ablation of meningeal cells by 6-hydroxydopamine. Brain Res Dev Brain Res 1997,98:15-20.
24. Elder GA, Tezapsidis N, Carter J, Shioi C, Bouras HC, Li JM, et al.: Identification and neuron specific expression of the S182/presenilin I protein in human and rodent brains. J Neurosci Res 1996, 45:308-320.
25. Perris R, Johansson S: Inhibition of neural crest stem cell migration by aggregating chondroitin sulfate proteoglycans is mediated by their hyaluron-binding region. Dev Biol 1990, 137:1-12.
26. Grumet M, Friedlander DR, Sakurai T: Functions of brain chondroitin sulfate proteoglycans during development: Interactions with adhesion molecules. Perspect Dev Neurobiol 1996, 3:319-330.
27. Ogawa M, Miyata T, Nakajima K, Yagyu K, Seike M, Ikenaka K, et al.: The reeler gene-associated antigen on Cajal-Retzius neurons is a crucial molecule for laminar organization of cortical neurons. Neuron 1995, 14:899-912.
28. Meyer-Puttlitz B, Junkner E, Margolis RM, Margolis RU: Chondoitin sulfate proteoglycans in the developing central nervous system. II. Immunocytochemical localisation of neurocan and phosphocan. J Comp Neurol 1996, 366:44-55.
29. Williams RS, Swisher CN, Jennings M: Cerebro-ocular dysgenesis (Walker-Warburg syndrome): Neuropathologic and etiologic analysis. Neurology 1984, 34:1531-1541.
30. Ellison D, Love S: Neuropathology. London: Mosby; 1998.
31. Lazjuk GI, Lurie IW, Ostrowskaja TI, Cherstvoi ED, Kirillova IA, Nedzved MK, et al.: brief clinical observations: The Neu-Laxova syndrome - A distinct entity. Am J Med Genet 1979, 3:261-267.
32. Takada K, Nakamura H, Suzumori K, Ishikawa T, Sugiyama N: Cortical dysplasia in a 23-week fetus with Fukuyama congenital muscular dystrophy (FCMD). Acta Neuropathol 1987, 74:300-306.
33. Lyon G, Raymond G, Mogami K, Gadisseux JF, Della Giustina E: Disorder of cerebellar foliation in Walker's lissencephaly and neu-laxova syndrome. J Neuropathol Exp Neurol 1993, 52:633-639.
34. Choi BH, Matthias SC: Cortical dysplasia associated with massive ectopia of neurons and glial cells within the subarachnoid space. Acta Neuropathol 1987, 73:105-109.
35. Georges-Labouesse E, Mark M, Messadeq N, Gansmüller A: Essential role of alpha 6 integrins in cortical and retinal lamination. Curr Biol 1998, 8:983-986.
36. Behar TN, Li YX, Tran HT, Ma W, Dunlap V, Scott C, Barker JL: GABA stimulates chemotaxis and chemokinesis of embryonic cortical neurons via calcium-dependent mechanisms. J Neurosci 1996, 16:1808-1818.
37. Hartmann D, Schulze M, Sievers J: Meningeal cells and cortical development: An in vitro analysis of the developing mouse and rat brain. J Anat 1996, 189:228.
38. Hartmann D, Ziegenhagen M, Sievers J: Meningeal cells stimulate neuronal migration and the formation of radial glial fascicles from the cerebellar external granular layer. Neurosci Lett 1998, 244:129-132.
39. Hartmann D, Schulze M, Sievers J: Meningeal cells stimulate and direct the migration of cerebellar external granule cells in vitro. J Neurocytol 1998, 27:395-409.
40. Derer P, Nakanishi S: Extracellular matrix distribution during neocortical wall ontogenesis in "normal" and "Reeler" mice. J Hirnforsch 1983, 24:209-224.
41. Maeda N, Hamanaka H, Oohira A, Noda M: Purification, characterisation and developmental expression of a brain-specific chondroitin sulfate proteoglycan, 6B4 proteoglycan/phosphocan. Neuroscience 1995, 67:23-35.
42. D'Arcangelo G, Miao GG, Chen SC, Soares HD, Morgan JI, Curran T: A protein related to extracellular matrix proteins deleted in the mouse mutant reeler. Nature 1995, 374:719-723.
43. Goffinet AM: Events governing organization of postmigratory neurons: Studies on brain development in normal and reeler mice. Brain Res Rev 1984, 7:261-296
44. Caviness VS, Crandall JE, Edwards MA: The reeler malformation: Implications for neocortical histogenesis. Cerebral Cortex 1988, 7:59-90
45. Stumpo DJ, Bock CB, Turtle JS, Blackshear PJ: MARCKS deficiency in mice leads to abnormal brain development and perinatal death. Proc Natl Acad Sci USA 1995, 92:944-948.
46. Blackshear PJ, Silver J, Nairn AC, Sulik KK, Squier MV, Stumpo DJ, et al.: Widespread neuronal ectopia associated with secondary defects in cerebrocortical chondroitin sulfate proteoglycans and basal lamina in MARCKS-deficient mice. Exp Neurol 1997, 145:46-61.
47. Frotscher M: Dual role of Cajal-Retzius cells and reelin in cortical development. Cell Tissue Res 1997, 290:315-322.
48. Joutel A, COrpechot C, Ducros A, Vahedi K, Chabriat H, Mouton P, et al.: Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature 1996, 383:707-710.
49. Ruchoux MM, Maurage CA: CADASIL: Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. J Neuropathol Exp Neurol 1997, 56:947-964.
50. Ruchoux MM, Maurage CA: Endothelial changes in muscle and skin biopsies in patients with CADASIL. Neuropathol Appl Neurobiol 1998, 24:60-65.
51. Naruse S, Thinakaran G, Luo JJ, Kusiak JW, Tomita T, et al.: Effects of PS1 deficiency on membrane protein trafficking in neurons. Neuron 1998, 21:1213-1221.
52. De Bergeyck V, Naerhuyzen B, Goffinet AM, Rouvroit CM: A panel of monoclonal antibodies against reelin, the extracellular matrix protein defective in reeler mutant mice. J Neurosc Meth 1998, 82:17-24.